Matches in SemOpenAlex for { <https://semopenalex.org/work/W2615667345> ?p ?o ?g. }
- W2615667345 endingPage "11444" @default.
- W2615667345 startingPage "11431" @default.
- W2615667345 abstract "Elevated cellular response to hypoxia, which contributes to cell transformation and tumor progression, is a prominent feature of malignant cells in solid tumors. Polo-like kinase 3 (Plk3) is a serine/threonine protein kinase known to inhibit the cellular response to hypoxia and tumorigenesis. Nickel compounds are well-established human carcinogens that induce tumorigenesis partly through their hypoxia-mimicking effects. Despite previous research efforts, the role of Plk3 in the hypoxic response induced by hypoxia or nickel is not completely understood. Here, we show that NiCl2 (Ni(II)) or hypoxia reduces the protein level and shortens the half-life of cytoplasmic Plk3 in a ubiquitin-proteasome-dependent manner. We identify SIAH2, a RING finger E3 ubiquitin ligase associated with the cellular hypoxic response, to be the ubiquitin E3 ligase that mediates the degradation of Plk3. We show that SIAH2 binds to Plk3 and mediates its ubiquitination primarily through its polo-box domain. We report that USP28, a deubiquitinase known to be inhibitable by Ni(II) or hypoxia, may also contribute to the suppression of the Plk3 protein by Ni(II). We also show that Plk3 in turn suppresses the SIAH2 protein level in a kinase activity-dependent manner. Our study revealed an interesting mutual regulation between Plk3 and SIAH2 and uncovered a regulatory network that functions to fine-tune the cellular hypoxic response. We propose that suppression of Plk3 expression contributes to carcinogenesis and tumor progression induced by nickel compounds. Elevated cellular response to hypoxia, which contributes to cell transformation and tumor progression, is a prominent feature of malignant cells in solid tumors. Polo-like kinase 3 (Plk3) is a serine/threonine protein kinase known to inhibit the cellular response to hypoxia and tumorigenesis. Nickel compounds are well-established human carcinogens that induce tumorigenesis partly through their hypoxia-mimicking effects. Despite previous research efforts, the role of Plk3 in the hypoxic response induced by hypoxia or nickel is not completely understood. Here, we show that NiCl2 (Ni(II)) or hypoxia reduces the protein level and shortens the half-life of cytoplasmic Plk3 in a ubiquitin-proteasome-dependent manner. We identify SIAH2, a RING finger E3 ubiquitin ligase associated with the cellular hypoxic response, to be the ubiquitin E3 ligase that mediates the degradation of Plk3. We show that SIAH2 binds to Plk3 and mediates its ubiquitination primarily through its polo-box domain. We report that USP28, a deubiquitinase known to be inhibitable by Ni(II) or hypoxia, may also contribute to the suppression of the Plk3 protein by Ni(II). We also show that Plk3 in turn suppresses the SIAH2 protein level in a kinase activity-dependent manner. Our study revealed an interesting mutual regulation between Plk3 and SIAH2 and uncovered a regulatory network that functions to fine-tune the cellular hypoxic response. We propose that suppression of Plk3 expression contributes to carcinogenesis and tumor progression induced by nickel compounds." @default.
- W2615667345 created "2017-05-26" @default.
- W2615667345 creator A5003731949 @default.
- W2615667345 creator A5017804624 @default.
- W2615667345 creator A5028009429 @default.
- W2615667345 creator A5048237280 @default.
- W2615667345 creator A5062982950 @default.
- W2615667345 date "2017-07-01" @default.
- W2615667345 modified "2023-10-01" @default.
- W2615667345 title "Mutual regulation between Polo-like kinase 3 and SIAH2 E3 ubiquitin ligase defines a regulatory network that fine-tunes the cellular response to hypoxia and nickel" @default.
- W2615667345 cites W1968438075 @default.
- W2615667345 cites W1971936302 @default.
- W2615667345 cites W1999042605 @default.
- W2615667345 cites W2007914815 @default.
- W2615667345 cites W2022031287 @default.
- W2615667345 cites W2034201397 @default.
- W2615667345 cites W2034894297 @default.
- W2615667345 cites W2036782096 @default.
- W2615667345 cites W2039291069 @default.
- W2615667345 cites W2041228090 @default.
- W2615667345 cites W2048667125 @default.
- W2615667345 cites W2049613540 @default.
- W2615667345 cites W2055128365 @default.
- W2615667345 cites W2061646337 @default.
- W2615667345 cites W2063659487 @default.
- W2615667345 cites W2064256444 @default.
- W2615667345 cites W2069364461 @default.
- W2615667345 cites W2072992526 @default.
- W2615667345 cites W2074245850 @default.
- W2615667345 cites W2080672462 @default.
- W2615667345 cites W2085512260 @default.
- W2615667345 cites W2092076201 @default.
- W2615667345 cites W2092096928 @default.
- W2615667345 cites W2093484703 @default.
- W2615667345 cites W2114909117 @default.
- W2615667345 cites W2118086887 @default.
- W2615667345 cites W2121872193 @default.
- W2615667345 cites W2126244927 @default.
- W2615667345 cites W2128551987 @default.
- W2615667345 cites W2134299378 @default.
- W2615667345 cites W2140364596 @default.
- W2615667345 cites W2147917253 @default.
- W2615667345 cites W2148614612 @default.
- W2615667345 cites W2165179747 @default.
- W2615667345 cites W2291679705 @default.
- W2615667345 cites W2307798789 @default.
- W2615667345 cites W2531635260 @default.
- W2615667345 cites W3205358246 @default.
- W2615667345 doi "https://doi.org/10.1074/jbc.m116.767178" @default.
- W2615667345 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5500808" @default.
- W2615667345 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28515325" @default.
- W2615667345 hasPublicationYear "2017" @default.
- W2615667345 type Work @default.
- W2615667345 sameAs 2615667345 @default.
- W2615667345 citedByCount "14" @default.
- W2615667345 countsByYear W26156673452017 @default.
- W2615667345 countsByYear W26156673452018 @default.
- W2615667345 countsByYear W26156673452019 @default.
- W2615667345 countsByYear W26156673452020 @default.
- W2615667345 countsByYear W26156673452021 @default.
- W2615667345 countsByYear W26156673452022 @default.
- W2615667345 countsByYear W26156673452023 @default.
- W2615667345 crossrefType "journal-article" @default.
- W2615667345 hasAuthorship W2615667345A5003731949 @default.
- W2615667345 hasAuthorship W2615667345A5017804624 @default.
- W2615667345 hasAuthorship W2615667345A5028009429 @default.
- W2615667345 hasAuthorship W2615667345A5048237280 @default.
- W2615667345 hasAuthorship W2615667345A5062982950 @default.
- W2615667345 hasBestOaLocation W26156673451 @default.
- W2615667345 hasConcept C102658986 @default.
- W2615667345 hasConcept C104317684 @default.
- W2615667345 hasConcept C134459356 @default.
- W2615667345 hasConcept C1491633281 @default.
- W2615667345 hasConcept C184235292 @default.
- W2615667345 hasConcept C25602115 @default.
- W2615667345 hasConcept C29537977 @default.
- W2615667345 hasConcept C502942594 @default.
- W2615667345 hasConcept C55493867 @default.
- W2615667345 hasConcept C555283112 @default.
- W2615667345 hasConcept C84815855 @default.
- W2615667345 hasConcept C86803240 @default.
- W2615667345 hasConcept C95444343 @default.
- W2615667345 hasConceptScore W2615667345C102658986 @default.
- W2615667345 hasConceptScore W2615667345C104317684 @default.
- W2615667345 hasConceptScore W2615667345C134459356 @default.
- W2615667345 hasConceptScore W2615667345C1491633281 @default.
- W2615667345 hasConceptScore W2615667345C184235292 @default.
- W2615667345 hasConceptScore W2615667345C25602115 @default.
- W2615667345 hasConceptScore W2615667345C29537977 @default.
- W2615667345 hasConceptScore W2615667345C502942594 @default.
- W2615667345 hasConceptScore W2615667345C55493867 @default.
- W2615667345 hasConceptScore W2615667345C555283112 @default.
- W2615667345 hasConceptScore W2615667345C84815855 @default.
- W2615667345 hasConceptScore W2615667345C86803240 @default.
- W2615667345 hasConceptScore W2615667345C95444343 @default.
- W2615667345 hasFunder F4320337361 @default.
- W2615667345 hasIssue "27" @default.
- W2615667345 hasLocation W26156673451 @default.